AI assistant
Sending…
Arctic Bioscience — Director's Dealing 2024
Mar 15, 2024
3536_dirs_2024-03-15_bcd049cb-fd04-483e-b507-258071141959.pdf
Director's Dealing
Open in viewerOpens in your device viewer
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Yuming Feng | |||
| Options agreement extended with Global Nutrios Consulting LLC, a legal person closely associated with Yuming Feng. |
|||||
| 2 | Reason for the notification | ||||
| a) | Position/status | EVP Global Business Development | |||
| b) | Initial notification / Amendment | Initial notice | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
| a) | Name | Arctic Bioscience AS | |||
| b) | LEI | 549300Z2HW6I989Q2C78 | |||
| 4 | Details of the transaction(s): section to the repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument |
Acceptance of share options in Arctic Bioscience AS (extension of agreement) |
|||
| Identification code | |||||
| NO0010859580 | |||||
| b) | Nature of the transaction | Share Purchase | |||
| c) | Price(s) and volume(s) | Price(s): | Volume(s): | ||
| 27,90 | 100 000 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
|||||
| - Price |
|||||
| e) | Date of the transaction | 2024-03-15 | |||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Daniele Mancinelli | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | CTO | |||
| b) | Initial notification / Amendment | Initial notice | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
| a) | Name | Arctic Bioscience AS | |||
| b) | LEI | 549300Z2HW6I989Q2C78 | |||
| 4 | Details of the transaction(s): section to the repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument |
Acceptance of share options in Arctic Bioscience AS (extension of agreement) |
|||
| Identification code | |||||
| b) | Nature of the transaction | NO0010859580 Share Purchase |
|||
| c) | Price(s) and volume(s) | Price(s): | Volume(s): | ||
| 9,845 | 51 570 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
|||||
| - Price |
|||||
| e) | Date of the transaction | 2024-03-15 | |||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Hogne Hallaråker | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | CSO | |||
| b) | Initial notification / Amendment | Initial notice | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
| a) | Name | Arctic Bioscience AS | |||
| b) | LEI | 549300Z2HW6I989Q2C78 | |||
| 4 | Details of the transaction(s): section to the repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument |
Acceptance of share options in Arctic Bioscience AS (extension of agreement) |
|||
| Identification code | |||||
| b) | Nature of the transaction | NO0010859580 Share Purchase |
|||
| c) | Price(s) and volume(s) | Price(s): | Volume(s): | ||
| 9,845 | 33 030 | ||||
| d) | Aggregated information | ||||
| - Aggregated volume |
|||||
| - Price |
|||||
| e) | Date of the transaction | 2024-03-15 | |||
| f) | Place of the transaction | Outside a trading venue |
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
|---|---|---|---|---|---|
| a) | Name | Per Christian Sæbø | |||
| 2 | Reason for the notification | ||||
| a) | Position/status | COO | |||
| b) | Initial notification / Amendment | Initial notice | |||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
| a) | Name | Arctic Bioscience AS | |||
| b) | LEI | 549300Z2HW6I989Q2C78 | |||
| 4 | Details of the transaction(s): section to the repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
| a) | Description of the financial instrument, type of instrument |
Acceptance of share options in Arctic Bioscience AS (extension of agreement) |
|||
| Identification code | |||||
| b) | Nature of the transaction | NO0010859580 Share Purchase |
|||
| c) | Price(s) and volume(s) | Price(s): 9,845 |
Volume(s): 57 390 |
||
| d) | Aggregated information | ||||
| - Aggregated volume |
|||||
| - Price |
|||||
| e) | Date of the transaction | 2024-03-15 | |||
| f) | Place of the transaction | Outside a trading venue |
More from Arctic Bioscience
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 13
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 7